Differential impact of nevirapine on artemether-lumefantrine pharmacokinetics in individuals stratified by CYP2B6 c.516G>T genotypes by Abdullahi, ST, Soyinka, JO, Olagunju, A, Bolarinwa, RA, Olarewaju, OJ, Bakare-Odunola, MT, Winterberg, M, Tarning, J, Owen, A, Khoo, S

CYP2B6*6 genotype specific differences in artemether‐lumefantrine disposition in healthy volunteers by Abdullahi, ST, Soyinka, JO, Olagunju, A, Bolarinwa, RA, Olarewaju, OJ, Bakare-Odunola, MT, Winterberg, M, Tarning, J, Owen, A, Khoo, S

The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children by Bienczak, A, Cook, A, Wiesner, L, Olagunju, A, Mulenga, V, Kityo, C, Kekitiinwa, A, Owen, A, Walker, A, Gibb, D, McIlleron, H, Burger, D, Denti, P